AstraZeneca Pharma India Limited Peer Comparison
ASTRAZEN · Healthcare · Current price ₹5,932
Peers tracked
11
AstraZeneca Pharma India Limited P/E
79.1x
Sector
Healthcare
AstraZeneca Pharma India Limited vs peers
| Company | Price | P/E | Market cap (Cr) |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,758.8 | 36.9x | 4,22,273 |
| Divi's Laboratories Limited | ₹9,144.5 | 85.4x | 2,44,762 |
| Torrent Pharmaceuticals Limited | ₹4,558.9 | 86.9x | 1,73,442 |
| Zydus Lifesciences Limited | ₹1,123 | 24.3x | 1,12,149 |
| Laurus Labs Limited | ₹2,060.1 | 95.9x | 1,11,250 |
| Cipla Limited | ₹1,325.1 | 33.2x | 1,07,043 |
| Dr. Reddy's Laboratories Limited | ₹1,233 | 29.9x | 1,02,815 |
| Aurobindo Pharma Limited | ₹1,666.9 | 25.9x | 95,513 |
| Mankind Pharma Limited | ₹2,275.5 | 44.9x | 93,968 |
| Lupin Limited | ₹1,961.6 | 17.1x | 89,437 |
| AstraZeneca Pharma India Limited | ₹5,970.5 | 101.1x | 14,915 |
AstraZeneca Pharma India Limited versus its peers
AstraZeneca Pharma India Limited operates in the Healthcare space alongside 11 tracked peers. Comparing valuation multiples within a sector is far more meaningful than in isolation — a P/E of 79.1x may be cheap in one industry and expensive in another.
More on AstraZeneca Pharma India Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.